갱년기장애 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 6.5%의 연평균 성장률(CAGR)로 242억 8,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 인지 건강, 직장 내 웰니스 프로그램, 정신건강 통합, 교육 및 인식 개선 캠페인, 맞춤형 의료에 대한 관심에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 갱년기 디지털 건강 솔루션, 비호르몬 요법, 장기적인 건강 결과에 대한 연구, 원격의료 및 가상 건강, 치료의 기술 혁신 등이 있습니다.
여성들의 운동 부족이 증가함에 따라 향후 몇 년간 갱년기장애 시장의 성장을 촉진할 것으로 예상됩니다. 신체적 비활동은 여가, 출퇴근, 일상 업무 등 신체 활동이 거의 없는 상태로 정의되며, 갱년기 증상 악화 및 건강 위험 증가로 이어집니다. 이러한 추세는 갱년기 관련 건강 문제를 관리하고 여성의 전반적인 웰빙을 지원하는 제품 및 서비스에 대한 수요를 증가시키고 있습니다. 예를 들어, 2024년 6월 세계보건기구(WHO)는 2022년 전 세계 성인의 27%가 신체적으로 비활동적인 상태이며, 2030년에는 이 수치가 35%에 달할 것으로 예상한다고 보고했습니다. 이에 따라 갱년기 시장에서는 여성의 신체활동 감소와 관련된 생활습관 및 건강 문제로 인해 맞춤형 솔루션에 대한 니즈가 지속적으로 증가하고 있습니다.
보다 건강한 생활습관 선택으로의 전환은 갱년기 질환 시장의 성장을 촉진할 것으로 예상됩니다. 균형 잡힌 식단, 규칙적인 운동, 더 나은 수면, 알코올 섭취 감소, 스트레스 해소 활동과 같은 생활습관의 변화는 갱년기 증상을 완화하고 이 자연적인 생물학적 단계에서 전반적인 건강을 증진하는 데 도움이 될 수 있습니다. 많은 여성들이 갱년기를 효과적으로 관리하기 위해 생활습관을 조정하는 데 점점 더 많은 노력을 기울이고 있으며, 이는 건강 지향적인 트렌드를 반영하고 있습니다. 예를 들어, 미국에 본사를 둔 World Wellness Institute가 2023년 11월에 발표한 보고서에 따르면, 2022년 웰니스 경제는 세계 경제 생산의 5.6%를 차지할 것이며, 2027년까지 8.6%의 연평균 성장률(CAGR)로 8조 5,000억 달러에 달할 것으로 예측했습니다. 웰빙을 중시하는 라이프스타일을 추구하는 이러한 추세는 갱년기 관련 제품 및 서비스에 대한 수요를 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 갱년기장애 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 갱년기장애 시장 : 성장률 분석
- 세계의 갱년기장애 시장 실적 : 규모와 성장, 2019-2024
- 세계의 갱년기장애 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 갱년기장애 전체 시장(TAM)
제6장 시장 세분화
- 세계의 갱년기장애 시장 : 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 식이보충제
- 시판약(OTC)
- 세계의 갱년기장애 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 국소
- 경구
- 주사제
- 세계의 갱년기장애 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 소매
- 온라인 약국
- 세계의 갱년기장애 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 진단 센터
- 전문 클리닉
- 기타 최종사용자
- 세계의 갱년기장애 시장, 식이보충제 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 허브 보충제
- 비타민과 미네랄
- 식물성 에스트로겐
- 오메가 3 지방산
- 프로바이오틱스
- 세계의 갱년기장애 시장, 시판약(OTC) 의약품 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 호르몬 대체요법(HRT)
- 비호르몬성 OTC 제품
- 기분 변동에 대한 항우울제
- 수면 보조제
- 진통제
제7장 지역별·국가별 분석
- 세계의 갱년기장애 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 갱년기장애 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 갱년기장애 시장 : 경쟁 구도
- 갱년기장애 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Inc Overview, Products and Services, Strategy and Financial Analysis
- The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
- F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- AbbVie Inc.
- Bayer AG
- Novartis AG
- Sanofi S.A
- Abbott Laboratories Ltd.
- GSK plc
- Eli Lilly and Company
- Amgen Inc.
- Novo Nordisk A/S
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Astellas Pharma Inc.
- Sun Pharmaceutical Industries Limited
- Cipla Inc.
- Dr. Reddy's Laboratories Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 갱년기장애 시장 2029 : 새로운 기회를 제공하는 국가
- 갱년기장애 시장 2029 : 새로운 기회를 제공하는 부문
- 갱년기장애 시장 2029 : 성장 전략
제36장 부록
ksm
Menopause is a natural biological process signifying the cessation of a woman's menstrual cycles and reproductive years, officially diagnosed when there is a 12-month absence of a menstrual period. This phase is characterized by various physical and hormonal changes, denoting the conclusion of reproductive capabilities as the ovaries cease egg release, and the hormones progesterone and estrogen decline.
The primary treatments for menopause involve dietary supplements and over-the-counter (OTC) pharmaceutical products. Dietary supplements, distinct from regular food, serve to complement the diet. These treatments are administered topically, orally, or through injectables, and are distributed through channels such as hospitals, retail outlets, and online pharmacies. They cater to end users such as hospitals, diagnostic centers, specialty clinics, and others.
The menopause market research report is one of a series of new reports from The Business Research Company that provides menopause market statistics, including menopause industry global market size, regional shares, competitors with a menopause market share, detailed menopause market segments, market trends and opportunities, and any further data you may need to thrive in the menopause industry. This menopause market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The menopause market size has grown strongly in recent years. It will grow from $17.74 billion in 2024 to $18.85 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increased life expectancy, women's health awareness, nutritional supplements, healthcare access improvement, stress and lifestyle management, patient advocacy.
The menopause market size is expected to see strong growth in the next few years. It will grow to $24.28 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to cognitive health focus, wellness programs at workplace, mental health integration, education and awareness campaigns, personalized medicine. Major trends in the forecast period include digital health solutions for menopause, non-hormonal therapies, research on long-term health outcomes, telemedicine and virtual health, technological innovations in treatment.
The rising physical inactivity among women is anticipated to boost the growth of the menopause market in the coming years. Physical inactivity, defined as minimal engagement in physical movement-whether during leisure, commuting, or daily tasks-has been linked to worsened menopausal symptoms and increased health risks. This trend has heightened the demand for products and services that help manage menopause-related health issues and support women's overall well-being. For example, in June 2024, the World Health Organization (WHO) reported that 27% of adults globally were physically inactive in 2022, with this figure expected to reach 35% by 2030. Consequently, the need for targeted solutions in the menopause market continues to grow, driven by the lifestyle and health challenges associated with reduced physical activity among women.
The shift toward healthier lifestyle choices is expected to drive the growth of the menopause market. Lifestyle changes, such as adopting balanced diets, regular exercise, better sleep, reduced alcohol intake, and engaging in stress-relieving activities, can help alleviate menopausal symptoms and promote overall well-being during this natural biological phase. Many women are increasingly focusing on lifestyle adjustments to manage menopause effectively, reflecting a broader trend toward wellness. For instance, a November 2023 report by the Global Wellness Institute, a U.S.-based organization, noted that in 2022, the wellness economy accounted for 5.6% of global economic output, with projections indicating it could grow to $8.5 trillion by 2027 at an average annual growth rate of 8.6%. This trend toward wellness-focused lifestyles is fueling the demand for menopause-related products and services.
Prominent companies operating in the menopause market are concentrating on the development of innovative products, exemplified by the introduction of Your Meno Ease Capsules, aiming to better cater to the needs of existing consumers. Your Meno Ease Capsules represent a dietary supplement designed to alleviate menopausal symptoms among women. This supplement comprises a blend of vitamins, minerals, and various nutrients considered beneficial for women experiencing menopause. PharmaLinea Ltd., a Slovenia-based manufacturer specializing in menopausal dietary supplements, introduced Your Meno Ease Capsules in October 2022. This innovative product stands out due to its unique composition and clinically validated functionalities, targeting general alleviation of menopausal symptoms while offering additional benefits for mood, mental acuity, distress management, cardiovascular health, and bone wellness. The capsule contains 75 mg of Qratol, a resveratrol compound with multiple health advantages, along with 40 mg of Qsoy, a soy derivative known for its efficacy in reducing menopausal symptoms, complemented by 1.6 mg of vitamin B6.
In March 2022, Amyris, Inc., a US-based entity specializing in the production and advancement of menopausal pharmaceuticals, acquired MenoLabs LLC in a transaction whose financial details were undisclosed. This strategic acquisition is anticipated to expedite the company's growth trajectory and solidify a prominent standing within the menopausal sector. The incorporation of MenoLabs LLC into Amyris Inc.'s operational framework is expected to leverage the latter's scientific approach in addressing routine health and wellness concerns. MenoLabs LLC, a US-based health and technology enterprise, specializes in the development of treatments targeting menopause-related issues.
Major companies operating in the menopause market report are Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Abbott Laboratories Ltd., GSK PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., PADAGIS LLC, Serenity Pharmaceuticals LLC, ASCEND Therapeutics US LLC
North America was the largest region in the menopause market in 2024. The regions covered in the menopause market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the menopause market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The menopause market includes revenues earned by entities by providing hormone replacement therapies, selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Menopause Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on menopause market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for menopause ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The menopause market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment: Dietary Supplements; Over-The-Counter (OTC) Pharma Products
- 2) By Route Of Administration: Topical; Oral; Injectables
- 3) By Distribution Channel: Hospital; Retail; Online Pharmacies
- 4) By End User: Hospital; Diagnostic Centers; Specialty Clinics; Other End Users
- Subsegments:
- 1) By Dietary Supplements: Herbal Supplements; Vitamins And Minerals; Phytoestrogens; Omega-3 Fatty Acids; Probiotics
- 2) By Over-The-Counter (OTC) Pharma Products: Hormone Replacement Therapy (HRT); Non-Hormonal OTC Products; Antidepressants for Mood Swings; Sleep Aids; Pain Relievers
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc; The Procter & Gamble Company; F. Hoffmann-La Roche AG; Merck & Co. Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Menopause Market Characteristics
3. Menopause Market Trends And Strategies
4. Menopause Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Menopause Growth Analysis And Strategic Analysis Framework
- 5.1. Global Menopause PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Menopause Market Growth Rate Analysis
- 5.4. Global Menopause Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Menopause Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Menopause Total Addressable Market (TAM)
6. Menopause Market Segmentation
- 6.1. Global Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dietary Supplements
- Over-The-Counter (OTC) Pharma Products
- 6.2. Global Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical
- Oral
- Injectables
- 6.3. Global Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Retail
- Online Pharmacies
- 6.4. Global Menopause Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Diagnostic Centers
- Specialty Clinics
- Other End Users
- 6.5. Global Menopause Market, Sub-Segmentation Of Dietary Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Herbal Supplements
- Vitamins And Minerals
- Phytoestrogens
- Omega-3 Fatty Acids
- Probiotics
- 6.6. Global Menopause Market, Sub-Segmentation Of Over-The-Counter (OTC) Pharma Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hormone Replacement Therapy (HRT)
- Non-Hormonal OTC Products
- Antidepressants for Mood Swings
- Sleep Aids
- Pain Relievers
7. Menopause Market Regional And Country Analysis
- 7.1. Global Menopause Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Menopause Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Menopause Market
- 8.1. Asia-Pacific Menopause Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Menopause Market
- 9.1. China Menopause Market Overview
- 9.2. China Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Menopause Market
- 10.1. India Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Menopause Market
- 11.1. Japan Menopause Market Overview
- 11.2. Japan Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Menopause Market
- 12.1. Australia Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Menopause Market
- 13.1. Indonesia Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Menopause Market
- 14.1. South Korea Menopause Market Overview
- 14.2. South Korea Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Menopause Market
- 15.1. Western Europe Menopause Market Overview
- 15.2. Western Europe Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Menopause Market
- 16.1. UK Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Menopause Market
- 17.1. Germany Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Menopause Market
- 18.1. France Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Menopause Market
- 19.1. Italy Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Menopause Market
- 20.1. Spain Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Menopause Market
- 21.1. Eastern Europe Menopause Market Overview
- 21.2. Eastern Europe Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Menopause Market
- 22.1. Russia Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Menopause Market
- 23.1. North America Menopause Market Overview
- 23.2. North America Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Menopause Market
- 24.1. USA Menopause Market Overview
- 24.2. USA Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Menopause Market
- 25.1. Canada Menopause Market Overview
- 25.2. Canada Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Menopause Market
- 26.1. South America Menopause Market Overview
- 26.2. South America Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Menopause Market
- 27.1. Brazil Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Menopause Market
- 28.1. Middle East Menopause Market Overview
- 28.2. Middle East Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Menopause Market
- 29.1. Africa Menopause Market Overview
- 29.2. Africa Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Menopause Market Competitive Landscape And Company Profiles
- 30.1. Menopause Market Competitive Landscape
- 30.2. Menopause Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Menopause Market Other Major And Innovative Companies
- 31.1. AbbVie Inc.
- 31.2. Bayer AG
- 31.3. Novartis AG
- 31.4. Sanofi S.A
- 31.5. Abbott Laboratories Ltd.
- 31.6. GSK plc
- 31.7. Eli Lilly and Company
- 31.8. Amgen Inc.
- 31.9. Novo Nordisk A/S
- 31.10. Viatris Inc.
- 31.11. Teva Pharmaceutical Industries Ltd.
- 31.12. Astellas Pharma Inc.
- 31.13. Sun Pharmaceutical Industries Limited
- 31.14. Cipla Inc.
- 31.15. Dr. Reddy's Laboratories Ltd.
32. Global Menopause Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Menopause Market
34. Recent Developments In The Menopause Market
35. Menopause Market High Potential Countries, Segments and Strategies
- 35.1 Menopause Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Menopause Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Menopause Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
